Cell and Gene Therapy, Cell Therapy, Leadership
May 05, 2025
Cell and Gene Therapy, Cell Therapy, cGMP Manufacturing, Tech Transfer
March 11, 2025
RoslinCT and Ayrmid Pharma Ltd. Announce Their Intent to Enter Into a Strategic Partnership to Manufacture FDA Approved Cell Therapy Omisirge® (omidubicel-onlv)
![[WEBINAR] Building the Future of Cell based Therapy Trends, Technologies, and Transformations](https://www.roslinct.com/wp-content/uploads/2025/02/Screenshot-2025-02-11-085812-410x231.png)
Cell and Gene Therapy, Cell Therapy
February 11, 2025
[WEBINAR] Building the Future of Cell based Therapy Trends, Technologies, and Transformations
Cell Therapy, Leadership
November 04, 2024
RoslinCT Announces Appointment of Jessica Carmen as Chief Commercial Officer
![[EBOOK] Blog Series: SAB Perspectives](https://www.roslinct.com/wp-content/uploads/2024/10/Blog-post-template-website-407x271-1.jpg)
Cell and Gene Therapy, Cell Therapy
September 30, 2024
RoslinCT Wins Manufacturer of the Year at the 9th Massachusetts Manufacturing Awards Ceremony
Cell and Gene Therapy, SAB Insights
August 15, 2024
RoslinCT Blog Series: Scientific Advisory Board Perspectives
Cell and Gene Therapy, SAB Insights
June 27, 2024
RoslinCT Blog Series: Scientific Advisory Board Perspectives
Cell and Gene Therapy, Cell Therapy, Leadership
June 25, 2024